Stockholders' Equity and Non-controlling Interests - Summary of non-vested Restricted Stock (Details) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2024 USD ($) $ / shares shares	Sep. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	May 06, 2022 USD ($)	May 07, 2021 shares
Weighted Average Grant Date Fair Value
Stock offering, maximum sales value | $						$ 100.0
Deferred offering costs incurred | $	$ 0.1	$ 0.1	$ 0.1	$ 0.1
Deferred offering costs | $	0.0		$ 0.0		$ 0.0
Third Amended Plan
Shareholders' Equity
Conversion ratio			1
Maximum
Weighted Average Grant Date Fair Value
Deferred offering costs incurred | $	0.0		$ 0.0
Restricted shares
Weighted Average Grant Date Fair Value
Share-based compensation expense | $	0.9	$ 0.5	1.9	$ 1.4
Total unrecognized compensation costs related to non-vested stock awards | $	$ 2.8		$ 2.8		$ 2.3
Weighted average period over which unrecognized compensation costs is expected to be recognized			1 year 10 months 24 days		1 year 10 months 24 days
Restricted shares | Third Amended Plan
Shareholders' Equity
Maximum shares of common stock to be issued							1,900
Number of shares available for future grant	200		200
Time Based Unvested Restricted Shares
Number of Shares
Unvested at the beginning of the period (in shares)			347	260	260
Granted (in shares)			183	226
Vested (in shares)			(200)	(132)
Forfeited (in shares)				(1)
Unvested at the end of the period (in shares)	330	353	330	353	347
Weighted Average Grant Date Fair Value
Unvested at the beginning of the period (in dollars per share) | $ / shares			$ 11.15	$ 10.88	$ 10.88
Granted (in dollars per share) | $ / shares			11.26	10.92
Vested (in dollars per share) | $ / shares			11.25	10.21
Forfeited (in dollars per share) | $ / shares				12.22
Unvested at the end of the period (in dollars per share) | $ / shares	$ 11.14	$ 11.16	$ 11.14	$ 11.16	$ 11.15
Performance Based Unvested Restricted Shares
Number of Shares
Granted (in shares)			39
Unvested at the end of the period (in shares)	39		39
Weighted Average Grant Date Fair Value
Granted (in dollars per share) | $ / shares			$ 7.36
Unvested at the end of the period (in dollars per share) | $ / shares	$ 7.36		$ 7.36
Performance period			3 years
Performance Based Unvested Restricted Shares | Minimum
Shareholders' Equity
Cumulative performance period ranges			0.00%
Performance Based Unvested Restricted Shares | Maximum
Shareholders' Equity
Cumulative performance period ranges			150.00%